HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 44 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $24,000 | -53.8% | 72,858 | +0.0% | 0.01% | -50.0% |
| Q2 2020 | $52,000 | +116.7% | 72,850 | +0.0% | 0.02% | +100.0% |
| Q1 2020 | $24,000 | -50.0% | 72,849 | +8.9% | 0.01% | -35.3% |
| Q4 2019 | $48,000 | +4.3% | 66,900 | 0.0% | 0.02% | -5.6% |
| Q3 2019 | $46,000 | -58.6% | 66,900 | 0.0% | 0.02% | -64.0% |
| Q2 2019 | $111,000 | -30.2% | 66,900 | +5.0% | 0.05% | -51.5% |
| Q1 2019 | $159,000 | -11.2% | 63,724 | -14.4% | 0.10% | +18.4% |
| Q4 2018 | $179,000 | -41.9% | 74,420 | +6.5% | 0.09% | -47.3% |
| Q3 2018 | $308,000 | +124.8% | 69,900 | +83.9% | 0.16% | +166.1% |
| Q2 2018 | $137,000 | -50.0% | 38,000 | -50.0% | 0.06% | -23.5% |
| Q1 2018 | $274,000 | – | 76,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,280,185 | $9,755,000 | 1.01% |
| Cormorant Asset Management, LP | 201,000 | $1,532,000 | 0.24% |
| PUTNAM INVESTMENTS LLC | 575,692 | $4,386,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,113 | $870,000 | 0.01% |
| VANGUARD GROUP INC | 4,355,424 | $131,473,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 463,200 | $3,530,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,100 | $199,000,000 | 0.00% |
| Ironwood Financial, llc | 870 | $7,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 24,293 | $185,000 | 0.00% |
| Sonora Investment Management, LLC | 500 | $3,000 | 0.00% |